tiprankstipranks
EnBio Holdings, Inc. (JP:6092)
:6092
Japanese Market

EnBio Holdings, Inc. (6092) AI Stock Analysis

0 Followers

Top Page

JP:6092

EnBio Holdings, Inc.

(6092)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
¥787.00
▲(31.61% Upside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by deteriorating fundamentals—especially the sharp drop in operating cash flow and deeply negative free cash flow in 2025—along with weaker margins and elevated leverage. These risks are partially offset by strong technical momentum and an uptrend, while valuation is not supportive due to a negative P/E and only a modest dividend yield.
Positive Factors
Specialized remediation and land redevelopment model
EnBio's focus on soil/groundwater remediation plus converting cleaned sites into redevelopment opportunities creates durable, project-driven revenue streams. Technical expertise and long project cycles foster sticky client relationships with industrial and government customers and create entry barriers.
Negative Factors
Collapse in operating and free cash flow
A sharp drop to near-zero operating cash flow and a large negative free cash flow in 2025 materially erode financial flexibility. Persistent FCF holes force external financing, constrain capex and working-capital management, and increase risk that profitable accounting earnings do not translate to available cash.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized remediation and land redevelopment model
EnBio's focus on soil/groundwater remediation plus converting cleaned sites into redevelopment opportunities creates durable, project-driven revenue streams. Technical expertise and long project cycles foster sticky client relationships with industrial and government customers and create entry barriers.
Read all positive factors

EnBio Holdings, Inc. (6092) vs. iShares MSCI Japan ETF (EWJ)

EnBio Holdings, Inc. Business Overview & Revenue Model

Company Description
EnBio Holdings Co., Ltd. engages in soil and groundwater contamination, and renewable energy businesses in Japan. It imports and sells equipment, materials, and cleaning agents; and purchases, sells, and leases contaminated land. The company is al...

EnBio Holdings, Inc. Financial Statement Overview

Summary
Financials are pressured by a major cash flow breakdown: 2025 operating cash flow fell to near breakeven and free cash flow turned deeply negative after being positive in 2022–2024. Income statement profitability remains positive but weakened (net margin down to ~4% from ~7% in 2024) alongside a sharp revenue contraction in the latest period. Balance sheet leverage is still elevated (debt roughly around equity), and ROE has stepped down, reducing cushion if weakness persists.
Income Statement
58
Neutral
Balance Sheet
62
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2025Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue10.11B10.67B9.58B8.12B8.99B6.84B
Gross Profit2.45B2.65B2.48B2.76B2.43B1.89B
EBITDA1.08B1.35B1.25B1.76B1.59B985.09M
Net Income108.79M452.69M708.76M812.06M654.06M304.06M
Balance Sheet
Total Assets21.56B21.20B19.31B17.35B16.37B15.70B
Cash, Cash Equivalents and Short-Term Investments3.19B3.29B3.60B2.83B2.37B2.02B
Total Debt10.28B10.10B8.62B8.90B8.58B9.04B
Total Liabilities12.32B11.96B10.72B10.49B10.40B10.38B
Stockholders Equity9.15B9.14B8.49B6.79B5.89B5.29B
Cash Flow
Free Cash Flow0.00-1.44B584.36M826.37M1.25B-1.43B
Operating Cash Flow0.0021.92M1.66B1.99B2.41B297.16M
Investing Cash Flow0.00-1.60B-1.58B-1.77B-1.48B-2.16B
Financing Cash Flow0.001.27B638.92M240.73M-534.92M928.54M

EnBio Holdings, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price598.00
Price Trends
50DMA
691.05
Positive
100DMA
645.47
Positive
200DMA
631.20
Positive
Market Momentum
MACD
32.67
Negative
RSI
64.88
Neutral
STOCH
72.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6092, the sentiment is Positive. The current price of 598 is below the 20-day moving average (MA) of 769.00, below the 50-day MA of 691.05, and below the 200-day MA of 631.20, indicating a bullish trend. The MACD of 32.67 indicates Negative momentum. The RSI at 64.88 is Neutral, neither overbought nor oversold. The STOCH value of 72.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6092.

EnBio Holdings, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥10.63B6.232.33%-6.09%24.42%
69
Neutral
¥15.35B6.153.79%-0.03%84.08%
67
Neutral
¥20.96B9.633.27%7.63%11.84%
65
Neutral
¥12.79B8.302.63%18.27%-4.07%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
62
Neutral
¥6.61B-34.2624.34%80.81%
55
Neutral
¥6.66B-1.991.54%3.37%-27.47%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6092
EnBio Holdings, Inc.
817.00
318.76
63.98%
JP:4809
Paraca Inc.
2,069.00
507.30
32.48%
JP:7049
SHIKIGAKU Co., Ltd.
786.00
25.00
3.29%
JP:7987
Nakabayashi Co., Ltd.
594.00
158.23
36.31%
JP:9325
PHYZ Holdings, Inc.
1,193.00
396.06
49.70%
JP:9791
Biken Techno Corporation
1,409.00
550.57
64.14%

EnBio Holdings, Inc. Corporate Events

EnBio Holdings Lifts Sales and Operating Profit but Slides to Net Loss for Nine-Month Period
Feb 13, 2026
EnBio Holdings reported consolidated net sales of ¥9.1 billion for the nine months ended Dec. 31, 2025, up 11.1% year on year, with operating profit rising 33.1% to ¥1.1 billion and ordinary profit up 25.7% to ¥1.09 billion. Despite...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026